Zevra Therapeutics, Inc.
ZVRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$105,511 | -$46,049 | -$41,543 | -$8,555 |
| Dep. & Amort. | $6,389 | $1,006 | $944 | $257 |
| Deferred Tax | $15,374 | $0 | $0 | $16,198 |
| Stock-Based Comp. | $14,906 | $5,954 | $4,294 | $2,436 |
| Change in WC | -$6,640 | $5,883 | -$406 | -$357 |
| Other Non-Cash | $5,817 | -$329 | $17,994 | $460 |
| Operating Cash Flow | -$69,665 | -$33,535 | -$18,717 | $10,439 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$296 | -$93 | -$102 |
| Net Acquisitions | $0 | -$30,401 | -$14,090 | $0 |
| Inv. Purchases | -$41,161 | -$45,814 | -$22,536 | -$15,422 |
| Inv. Sales/Matur. | $25,000 | $59,121 | $36,626 | $0 |
| Other Inv. Act. | -$6,000 | $0 | -$36,626 | $0 |
| Investing Cash Flow | -$22,161 | -$17,390 | -$36,719 | -$15,524 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $16,290 | $25,587 | $12,784 | -$38,097 |
| Stock Issued | $64,516 | $0 | $0 | $49,285 |
| Stock Repurch. | $0 | -$3,447 | -$4,723 | -$2,814 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,302 | $6,324 | $291 | $104,735 |
| Financing Cash Flow | $82,108 | $28,464 | $8,352 | $113,109 |
| Forex Effect | $454 | $44 | $204 | $0 |
| Net Chg. in Cash | -$9,264 | -$22,417 | -$46,880 | $108,024 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $43,049 | $65,466 | $112,346 | $4,322 |
| End Cash | $33,785 | $43,049 | $65,466 | $112,346 |
| Free Cash Flow | -$69,665 | -$33,831 | -$18,810 | $10,337 |